Curis Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for CRIS, updated each market day.
CRIS AI Sentiment
AI sees no strong directional signal for Curis Inc stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Sector
Exchange
Market Cap
$20,389,133
Cap Tier
Employees
24
Headquarters
LEXINGTON, MA
Listed Since
Aug. 1, 2000
Website
CRIS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CRIS Volatility
Curis Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
